Abstract
Background
Late complications following gastric cancer surgery, including postgastrectomy syndromes, are complex problems requiring a solution. Reported risk factors for developing late complications include surgery-related factors, such as the surgical approach and the extent of resection and reconstruction. However, this has not been assessed in a prospective study with a large sample size. Therefore, this study aimed to evaluate associations between surgery-related factors and the development of late complications. Data from the JCOG0912 trial were used. It compared laparoscopy-assisted distal gastrectomy (LADG) to open distal gastrectomy (ODG) in clinical stage I gastric cancer patients.
Methods
This study included 881/921 patients enrolled in the JCOG0912 trial. The incidence of late complications was compared between the ODG and the LADG arms. In addition, associations between surgery-related factors and the development of late complications were assessed by multivariable analyses using the proportional odds model to identify relevant risk factors.
Results
There was no difference in the type or number of patients with late complications between the LADG and the ODG arms. The multivariable analysis for each late complication revealed that the Billroth-I reconstruction (vs. R-en-Y or Billroth-II) had a lower risk of cholecystitis [odds ratio (OR) 0.187, 95% confidence interval (CI) 0.039–0.905, P = 0.037] or ileus (OR 0.116, 95%CI 0.033–0.406, P < 0.001), and pylorus-preserving gastrectomy (vs. R-en-Y or Billroth-II) had a higher risk of reflux esophagitis (OR 3.348, 95% CI 1.371–8.176, P = 0.008). The surgical approach was not a risk factor for any late complications.
Conclusion
Differences in surgical approaches did not constitute a risk for developing late complications after gastrectomy. Billroth-I reconstruction reduced the risk of ileus and cholecystitis, but pylorus-preserving gastrectomy carried a risk for reflux esophagitis.
Similar content being viewed by others
References
Sasako M, Sano T, Yamamoto S, Kurokawa Y, Nashimoto A, Kurita A et al (2008) D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med 359(5):453–462. https://doi.org/10.1056/NEJMoa0707035
Nakada K, Ikeda M, Takahashi M, Kinami S, Yoshida M, Uenosono Y et al (2015) Characteristics and clinical relevance of postgastrectomy syndrome assessment scale (PGSAS)-45: newly developed integrated questionnaires for assessment of living status and quality of life in postgastrectomy patients. Gastric Cancer 18(1):147–158. https://doi.org/10.1007/s10120-014-0344-4
Tsubono Y, Hisamichi S (2000) Screening for gastric cancer in Japan. Gastric Cancer 3(1):9–18. https://doi.org/10.1007/pl00011692
Liou JM, Malfertheiner P, Lee YC, Sheu BS, Sugano K, Cheng HC et al (2020) Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus. Gut 69(12):2093–2112. https://doi.org/10.1136/gutjnl-2020-322368
Suzuki H, Gotoda T, Sasako M, Saito D (2006) Detection of early gastric cancer: misunderstanding the role of mass screening. Gastric Cancer 9(4):315–319
Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F (2020) Gastric cancer. Lancet 396(10251):635–648. https://doi.org/10.1016/S0140-6736(20)31288-5
Ajani JA, Lee J, Sano T, Janjigian YY, Fan D, Song S (2017) Gastric adenocarcinoma. Nat Rev Dis Primers 1(3):17036. https://doi.org/10.1038/nrdp.2017.36
Kelly KJ, Selby L, Chou JF, Dukleska K, Capanu M, Coit DG et al (2015) Laparoscopic versus open gastrectomy for gastric adenocarcinoma in the west: a case-control study. Ann Surg Oncol 22(11):3590–3596. https://doi.org/10.1245/s10434-015-4381-y
Kinami S, Takahashi M, Urushihara T, Ikeda M, Yoshida M, Uenosono Y et al (2018) Background factors influencing postgastrectomy syndromes after various types of gastrectomy. World J Clin Cases 6(16):1111–1120. https://doi.org/10.12998/wjcc.v6.i16.1111
Nunobe S, Sasako M, Saka M, Fukagawa T, Katai H, Sano T (2007) Symptom evaluation of long-term postoperative outcomes after pylorus-preserving gastrectomy for early gastric cancer. Gastric Cancer 10(3):167–172. https://doi.org/10.1007/s10120-007-0434-7
Fujita J, Takahashi M, Urushihara T, Tanabe K, Kodera Y, Yumiba T et al (2016) Assessment of postoperative quality of life following pylorus-preserving gastrectomy and Billroth-I distal gastrectomy in gastric cancer patients: results of the nationwide postgastrectomy syndrome assessment study. Gastric Cancer 19(1):302–311. https://doi.org/10.1007/s10120-015-0460-9
Isozaki H, Okajima K, Momura E, Ichinona T, Fujii K, Izumi N et al (1996) Postoperative evaluation of pylorus-preserving gastrectomy for early gastric cancer. Br J Surg 83(2):266–269
Bai DS, Jin SJ, Qian JJ, Zhang C, Zhou BH, Jiang GQ (2021) Modified (Bai-Jiang style) vagus nerve-preserving versus conventional laparoscopic splenectomy and azygoportal disconnection: a randomized clinical trial. Surg Endosc 35(4):1786–1795. https://doi.org/10.1007/s00464-020-07573-w
Nakamura K, Katai H, Mizusawa J, Yoshikawa T, Ando M, Terashima M et al (2013) A phase III study of laparoscopy-assisted versus open distal gastrectomy with nodal dissection for clinical stage IA/IB gastric cancer (JCOG0912). Jpn J Clin Oncol 43(3):324–327. https://doi.org/10.1093/jjco/hys220
Katai H, Mizusawa J, Katayama H, Takagi M, Yoshikawa T, Fukagawa T et al (2017) Short-term surgical outcomes from a phase III study of laparoscopy-assisted versus open distal gastrectomy with nodal dissection for clinical stage IA/IB gastric cancer: Japan clinical oncology group study JCOG0912. Gastric Cancer 20(4):699–708. https://doi.org/10.1007/s10120-016-0646-9
Katai H, Mizusawa J, Katayama H, Morita S, Yamada T, Bando E et al (2020) Survival outcomes after laparoscopy-assisted distal gastrectomy versus open distal gastrectomy with nodal dissection for clinical stage IA or IB gastric cancer (JCOG0912): a multicentre, non-inferiority, phase 3 randomised controlled trial. Lancet Gastroenterol Hepatol 5(2):142–151. https://doi.org/10.1016/S2468-1253(19)30332-2
Japanese Gastric Cancer Association (1998) Japanese classification of gastric carcinoma—2nd English edition. Gastric Cancer 1(1):10–24
Scarpellini E, Arts J, Karamanolis G, Laurenius A, Siquini W, Suzuki H et al (2020) International consensus on the diagnosis and management of dumping syndrome. Nat Rev Endocrinol 16(8):448–466. https://doi.org/10.1038/s41574-020-0357-5
Katayama H, Kurokawa Y, Nakamura K, Ito H, Kanemitsu Y, Masuda N et al (2016) Extended Clavien–Dindo classification of surgical complications: Japan clinical oncology group postoperative complications criteria. Surg Today 46(6):668–685. https://doi.org/10.1007/s00595-015-1236-x
Noh SM, Jeong HY, Cho JS, Shin KS, Song KS, So Y et al (2003) New type of reconstruction method after subtotal gastrectomy (Noh’s operation). World J Surg 27(5):562–566. https://doi.org/10.1007/s00268-003-6830-1
Ishigami S, Natsugoe S, Hokita S, Aoki T, Kashiwagi H, Hirakawa K et al (2011) Postoperative long-term evaluation of interposition reconstruction compared with Roux-en-Y after total gastrectomy in gastric cancer: prospective randomized controlled trial. Am J Surg 202(3):247–253. https://doi.org/10.1016/j.amjsurg.2011.04.004
Hosoda K, Mieno H, Ema A, Ushiku H, Washio M, Song I et al (2020) Delta-shaped anastomosis vs circular stapler anastomosis after laparoscopic distal gastrectomy with Billroth I reconstruction: a randomized controlled trial. Asian J Endosc Surg 13(3):301–310. https://doi.org/10.1111/ases.12770
Svedlund J, Sullivan M, Liedman B, Lundell L, Sjödin I (1997) Quality of life after gastrectomy for gastric carcinoma: controlled study of reconstructive procedures. World J Surg 21(4):422–433. https://doi.org/10.1007/pl00012265
Gioffre’ Florio MA, Bartolotta M, Miceli JC, Giacobbe G, Saitta FP, Paparo MT et al (2000) Simple versus double jejunal pouch for reconstruction after total gastrectomy. Am J Surg 180(1):24–28. https://doi.org/10.1016/s0002-9610(00)00419-0
Adachi S, Inagawa S, Enomoto T, Shinozaki E, Oda T, Kawamoto T (2003) Subjective and functional results after total gastrectomy: prospective study for longterm comparison of reconstruction procedures. Gastric Cancer 6(1):24–29. https://doi.org/10.1007/s101200300003
Yoo CH, Sohn BH, Han WK, Pae WK (2005) Proximal gastrectomy reconstructed by jejunal pouch interposition for upper third gastric cancer: prospective randomized study. World J Surg 29(12):1592–1599. https://doi.org/10.1007/s00268-005-7793-1
Kalmár K, Káposztás Z, Varga G, Cseke L, Papp A, Horváth OP (2008) Comparing aboral versus oral pouch with preserved duodenal passage after total gastrectomy: does the position of the gastric substitute reservoir count? Gastric Cancer 11(2):72–80. https://doi.org/10.1007/s10120-008-0455-x
Zonča P, Malý T, Ihnát P, Peteja M, Kraft O, Kuca K (2016) J-pouch versus Roux-en-Y reconstruction after gastrectomy: functional assessment and quality of life (randomized trial). Onco Targets Ther 16(10):13–19. https://doi.org/10.2147/OTT.S99628
Ikegame K, Hikage M, Fujiya K, Kamiya S, Tanizawa Y, Bando E et al (2021) The effect of minimally invasive gastrectomy for gastric cancer on postoperative gallstone formation. World J Surg 45(11):3378–3385. https://doi.org/10.1007/s00268-021-06270-6
Gutt CN, Oniu T, Schemmer P, Mehrabi A, Büchler MW (2004) Fewer adhesions induced by laparoscopic surgery? Surg Endosc 18(6):898–906. https://doi.org/10.1007/s00464-003-9233-3
Kim KM, An JY, Kim HI, Cheong JH, Hyung WJ, Noh SH (2012) Major early complications following open, laparoscopic and robotic gastrectomy. Br J Surg 99(12):1681–1687. https://doi.org/10.1002/bjs.8924
Paik KH, Lee JC, Kim HW, Kang J, Lee YS, Hwang JH et al (2016) Risk factors for gallstone formation in resected gastric cancer patients. Medicine (Baltimore) 95(15):e3157. https://doi.org/10.1097/MD.0000000000003157
Fukagawa T, Katai H, Saka M, Morita S, Sano T, Sasako M (2009) Gallstone formation after gastric cancer surgery. J Gastrointest Surg 13(5):886–889. https://doi.org/10.1007/s11605-009-0832-8
Suh YS, Han DS, Kong SH, Kwon S, Shin CI, Kim WH et al (2014) Laparoscopy-assisted pylorus-preserving gastrectomy is better than laparoscopy-assisted distal gastrectomy for middle-third early gastric cancer. Ann Surg 259(3):485–493. https://doi.org/10.1097/SLA.0b013e318294d142
Kobayashi T, Hisanaga M, Kanehiro H, Yamada Y, Ko S, Nakajima Y (2005) Analysis of risk factors for the development of gallstones after gastrectomy. Br J Surg 92(11):1399–1403. https://doi.org/10.1002/bjs.5117
Wang CJ, Kong SH, Park JH, Choi JH, Park SH, Zhu CC et al (2021) Preservation of hepatic branch of the vagus nerve reduces the risk of gallstone formation after gastrectomy. Gastric Cancer 24(1):232–244. https://doi.org/10.1007/s10120-020-01106-z
Inokuchi M, Kojima K, Yamada H, Kato K, Hayashi M, Motoyama K et al (2013) Long-term outcomes of Roux-en-Y and Billroth-I reconstruction after laparoscopic distal gastrectomy. Gastric Cancer 16(1):67–73. https://doi.org/10.1007/s10120-012-0154-5
Hosoda K, Yamashita K, Sakuramoto S, Katada N, Moriya H, Mieno H et al (2017) Postoperative quality of life after laparoscopy-assisted pylorus-preserving gastrectomy compared With laparoscopy-assisted distal gastrectomy: a cross-sectional postal questionnaire survey. Am J Surg 213(4):763–770. https://doi.org/10.1016/j.amjsurg.2016.09.041
Eom BW, Park B, Yoon HM, Ryu KW, Kim YW (2019) Laparoscopy-assisted pylorus-preserving gastrectomy for early gastric cancer: a retrospective study of long-term functional outcomes and quality of life. World J Gastroenterol 25(36):5494–5504. https://doi.org/10.3748/wjg.v25.i36.5494
Kosuga T, Tsujiura M, Nakashima S, Masuyama M, Otsuji E (2021) Current status of function-preserving gastrectomy for gastric cancer. Ann Gastroenterol Surg 5(3):278–286. https://doi.org/10.1002/ags3.12430
Nagano H, Ohyama S, Sakamoto Y, Ohta K, Yamaguchi T, Muto T et al (2004) The endoscopic evaluation of gastritis, gastric remnant residue, and the incidence of secondary cancer after pylorus-preserving and transverse gastrectomies. Gastric Cancer 7(1):54–59. https://doi.org/10.1007/s10120-004-0269-4
Park DJ, Lee HJ, Jung HC, Kim WH, Lee KU, Yang HK (2008) Clinical outcome of pylorus-preserving gastrectomy in gastric cancer in comparison with conventional distal gastrectomy with Billroth I anastomosis. World J Surg 32(6):1029–1036. https://doi.org/10.1007/s00268-007-9441-4
Kubo M, Sasako M, Gotoda T, Ono H, Fujishiro M, Saito D et al (2002) Endoscopic evaluation of the remnant stomach after gastrectomy: proposal for a new classification. Gastric Cancer 5(2):83–89. https://doi.org/10.1007/s101200200014
Mao X, Xu X, Zhu H, Ji C, Lu X, Wang B (2020) A comparison between pylorus-preserving and distal gastrectomy in surgical safety and functional benefit with gastric cancer: a systematic review and meta-analysis. World J Surg Oncol 18(1):160. https://doi.org/10.1186/s12957-020-01910-y
Park DJ, Kim YW, Yang HK, Ryu KW, Han SU, Kim HH et al (2021) Short-term outcomes of a multicentre randomized clinical trial comparing laparoscopic pylorus-preserving gastrectomy with laparoscopic distal gastrectomy for gastric cancer (the KLASS-04 trial). Br J Surg 108(9):1043–1049. https://doi.org/10.1093/bjs/znab295
Funding
The study was supported in part by National Cancer Center Research and Development Funds (26-A-4, 29-A-3, 2020-J-3) and the Japan Agency for Medical Research and Development (Grant Number JP18ck0106317).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
Dr. Haruhiko Cho received personal fees from Ethicon, outside the submitted work. Dr. Naoki Hiki received grants and personal fees from Abbott Japan, EA, Johnson and Johnson, Otsuka, Kaken, Covidien Japan, Takeda, Daiichi Sankyo, Taiho, Tsumura, Terumo, MIYARISAN, grants from Shionogi, Chugai, HOGY medical, Yakult, personal fees from NHK, Pfizer, AstraZeneca, Nihon Pharma., Olympus, Novartis, Intuitive Surgical Japan, Ono, Kaigen, QLife, Sumitomo Dainippon, Nestlé Japan, outside the submitted work. Dr. Yasuhiro Choda received personal fees from Ono, Bristol-Myers Squibb, outside the submitted work. Dr. Narikazu Boku received personal fees from Taiho, Ono, Bristol-Myers Squibb, Daiichi Sankyo, outside the submitted work. Dr. Masanori Terashima received personal fees from Taiho, Chugai, Ono, Bristol-Myers Squibb, Yakult, Takeda, Eli Lilly, Pfizer, Daiichi Sankyo, Johnson and Johnson, Medtronic Japan, Intuitive Surgical Japan, Olympus, outside the submitted work. Drs. Makoto Hikage, Shinji Hato, Kohei Uemura, Masahiro Yura, Yuya Sato, Hisayuki Matsushita, Chikara Kunisaki, Kentaro Inoue, Takaki Yoshikawa, and Hitoshi Katai have no conflicts of interest or financial ties to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Hikage, M., Hato, S., Uemura, K. et al. Late complication after gastrectomy for clinical stage I cancer: supplementary analysis of JCOG0912. Surg Endosc 37, 2958–2968 (2023). https://doi.org/10.1007/s00464-022-09804-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-022-09804-8